BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 21993561)

  • 1. Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis.
    Spritz RA
    J Invest Dermatol; 2012 Feb; 132(2):268-73. PubMed ID: 21993561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in the genetics of generalized vitiligo.
    Spritz RA
    J Genet Genomics; 2011 Jul; 38(7):271-8. PubMed ID: 21777851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    Pigment Cell Res; 2007 Aug; 20(4):271-8. PubMed ID: 17630960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma.
    Spritz RA
    Genome Med; 2010 Oct; 2(10):78. PubMed ID: 20959028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual.
    Wang P; Li Y; Nie H; Zhang X; Shao Q; Hou X; Xu W; Hong W; Xu A
    J Dermatol Sci; 2016 Oct; 84(1):40-49. PubMed ID: 27470284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
    Jin Y; Birlea SA; Fain PR; Gowan K; Riccardi SL; Holland PJ; Mailloux CM; Sufit AJ; Hutton SM; Amadi-Myers A; Bennett DC; Wallace MR; McCormack WT; Kemp EH; Gawkrodger DJ; Weetman AP; Picardo M; Leone G; Taïeb A; Jouary T; Ezzedine K; van Geel N; Lambert J; Overbeck A; Spritz RA
    N Engl J Med; 2010 May; 362(18):1686-97. PubMed ID: 20410501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genetic Basis of Vitiligo.
    Spritz RA; Santorico SA
    J Invest Dermatol; 2021 Feb; 141(2):265-273. PubMed ID: 32778407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
    Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
    Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic architecture of vitiligo.
    Roberts GHL; Santorico SA; Spritz RA
    Pigment Cell Melanoma Res; 2020 Jan; 33(1):8-15. PubMed ID: 31743585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunogenetics of Vitiligo: An Approach Toward Revealing the Secret of Depigmentation.
    Dwivedi M; Laddha NC; Begum R
    Adv Exp Med Biol; 2022; 1367():61-103. PubMed ID: 35286692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study of generalized vitiligo in an isolated European founder population identifies SMOC2, in close proximity to IDDM8.
    Birlea SA; Gowan K; Fain PR; Spritz RA
    J Invest Dermatol; 2010 Mar; 130(3):798-803. PubMed ID: 19890347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.
    Spritz RA
    Thyroid; 2010 Jul; 20(7):745-54. PubMed ID: 20578892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo--part 1.
    Tarlé RG; Nascimento LM; Mira MT; Castro CC
    An Bras Dermatol; 2014; 89(3):461-70. PubMed ID: 24937821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Vitiligo.
    Spritz RA; Andersen GH
    Dermatol Clin; 2017 Apr; 35(2):245-255. PubMed ID: 28317533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1).
    Jin Y; Riccardi SL; Gowan K; Fain PR; Spritz RA
    J Invest Dermatol; 2010 Mar; 130(3):774-83. PubMed ID: 19727120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.
    Jin Y; Andersen G; Yorgov D; Ferrara TM; Ben S; Brownson KM; Holland PJ; Birlea SA; Siebert J; Hartmann A; Lienert A; van Geel N; Lambert J; Luiten RM; Wolkerstorfer A; Wietze van der Veen JP; Bennett DC; Taïeb A; Ezzedine K; Kemp EH; Gawkrodger DJ; Weetman AP; Kõks S; Prans E; Kingo K; Karelson M; Wallace MR; McCormack WT; Overbeck A; Moretti S; Colucci R; Picardo M; Silverberg NB; Olsson M; Valle Y; Korobko I; Böhm M; Lim HW; Hamzavi I; Zhou L; Mi QS; Fain PR; Santorico SA; Spritz RA
    Nat Genet; 2016 Nov; 48(11):1418-1424. PubMed ID: 27723757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.